Showing results (161-170 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|March 5, 2026
Enhancing cancer killing and natural killer cell persistence by targeting NOXA, a predictor of poor patient survivalSung-Bae Kang, Ji Hye Jeong, Seung Wook Kim, et al.
Molecular Therapy. Oncology|March 5, 2026
Beyond autologous ex vivo CAR-expressing cell therapies: Toward allogeneic and nucleated cell-free delivery systems of CARKathrine S Rallis, Laura M Dionisio, Mubin Tarannum, et al.
Molecular Therapy. Oncology|June 3, 2025
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphomaKun Yun, R Leo Sakemura, Ismail Can, et al.
Molecular Therapy. Oncology|May 25, 2026
Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotypeHaoran Xu, Marcus Chun Tao Wan, Chelsey Chi Ching Wong, et al.
Molecular Therapy. Oncology|May 21, 2026
Stem cell-directed targeted chemotherapy primes drug-resistant metastatic ovarian tumors for elimination by natural killer cellsMohammad Massumi, Geng Li, Hajar Owji, et al.
Molecular Therapy. Oncology|February 20, 2026
Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemiasAlexander W Rankin, Amy K Keating, Rolla F Abu-Arja, et al.
Molecular Therapy. Oncology|February 20, 2026
A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based constructAlexandros Kourtesakis, Hiu Nam Hannah Chow, Eileen Bailey, et al.
Molecular Therapy. Oncology|June 12, 2026
Mevalonate pathway activation in Ewing sarcoma reveals a 3D-specific synergy between statins and BCL-xL inhibitionBranka Radic-Sarikas, Marica Markovic, Martha Magdalena Zylka, et al.
Molecular Therapy. Oncology|April 23, 2026
CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunitiesKun-Wei Song, Aanchal Preet Kaur, Sneha Ramakrishna
Molecular Therapy. Oncology|March 26, 2026
Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastomaPavel Spirin, Andrey Shulgin, Timofey Lebedev, et al.
Pageof 41